Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Debt to Equity Over Time
Trending lower, above historical average.
Left:
||||
Debt-to-equity ratio
Latest
0.00
↑ 101% above average
Average (8y)
-0.09
Historical baseline
Range
High:0.06
Low:-0.32
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 0.00 | -97.9% |
| 2023 | 0.06 | +239.3% |
| 2022 | 0.02 | +157.7% |
| 2021 | 0.01 | -80.1% |
| 2020 | 0.03 | +139.2% |
| 2019 | -0.08 | +72.3% |
| 2018 | -0.30 | +5.9% |
| 2017 | -0.32 | -31.2% |
| 2016 | -0.24 | - |